why choose us

First received: May 11, 2023

Clinical Trial: A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lupus Erythematosus, Systemic

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Severe, Refractory Systemic Lupus Erythematosus (SL

Brief Summary: The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory Systemic Lupus Erythematosus (SLE).

Read more